Clinical Trials Logo

Clinical Trial Summary

The purpose of this post-marketing surveillance (PMS) is to observe the safety profile of Lenvima (lenvatinib) in normal clinical practice setting.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02764554
Study type Observational
Source Eisai Inc.
Contact
Status Completed
Phase
Start date November 10, 2016
Completion date September 29, 2021

See also
  Status Clinical Trial Phase
Completed NCT03239769 - Compare the Aesthetic Effect of Different Thyroidectomies N/A